WO2012131680A3 - Compositions and methods for treating inflammation based on inhibiting cd151 activity - Google Patents

Compositions and methods for treating inflammation based on inhibiting cd151 activity Download PDF

Info

Publication number
WO2012131680A3
WO2012131680A3 PCT/IL2012/050111 IL2012050111W WO2012131680A3 WO 2012131680 A3 WO2012131680 A3 WO 2012131680A3 IL 2012050111 W IL2012050111 W IL 2012050111W WO 2012131680 A3 WO2012131680 A3 WO 2012131680A3
Authority
WO
WIPO (PCT)
Prior art keywords
activity
inhibiting
compositions
methods
treating inflammation
Prior art date
Application number
PCT/IL2012/050111
Other languages
French (fr)
Other versions
WO2012131680A9 (en
WO2012131680A2 (en
Inventor
Einat TOISTER
Idit Shachar
Original Assignee
Yeda Research And Development Co. Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yeda Research And Development Co. Ltd. filed Critical Yeda Research And Development Co. Ltd.
Publication of WO2012131680A2 publication Critical patent/WO2012131680A2/en
Publication of WO2012131680A9 publication Critical patent/WO2012131680A9/en
Publication of WO2012131680A3 publication Critical patent/WO2012131680A3/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/70596—Molecules with a "CD"-designation not provided for elsewhere
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Abstract

An isolated peptide comprising at least 20 consecutive amino acids of the amino acid sequence set forth in SEQ ID NO: 2, the peptide being shorter than 100 amino acids and having a CD151 inhibitory activity. Also provided are uses of this peptide.
PCT/IL2012/050111 2011-03-28 2012-03-28 Compositions and methods for treating inflammation WO2012131680A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201161468109P 2011-03-28 2011-03-28
US61/468,109 2011-03-28

Publications (3)

Publication Number Publication Date
WO2012131680A2 WO2012131680A2 (en) 2012-10-04
WO2012131680A9 WO2012131680A9 (en) 2012-12-13
WO2012131680A3 true WO2012131680A3 (en) 2013-01-24

Family

ID=46051707

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/IL2012/050111 WO2012131680A2 (en) 2011-03-28 2012-03-28 Compositions and methods for treating inflammation

Country Status (1)

Country Link
WO (1) WO2012131680A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014159813A1 (en) 2013-03-13 2014-10-02 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010137020A1 (en) * 2009-05-28 2010-12-02 Yeda Research And Development Co. Ltd. Methods of treating inflammation

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL154600B (en) 1971-02-10 1977-09-15 Organon Nv METHOD FOR THE DETERMINATION AND DETERMINATION OF SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES.
NL154598B (en) 1970-11-10 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING LOW MOLECULAR COMPOUNDS AND PROTEINS THAT CAN SPECIFICALLY BIND THESE COMPOUNDS AND TEST PACKAGING.
NL154599B (en) 1970-12-28 1977-09-15 Organon Nv PROCEDURE FOR DETERMINING AND DETERMINING SPECIFIC BINDING PROTEINS AND THEIR CORRESPONDING BINDABLE SUBSTANCES, AND TEST PACKAGING.
US3901654A (en) 1971-06-21 1975-08-26 Biological Developments Receptor assays of biologically active compounds employing biologically specific receptors
US3853987A (en) 1971-09-01 1974-12-10 W Dreyer Immunological reagent and radioimmuno assay
US3867517A (en) 1971-12-21 1975-02-18 Abbott Lab Direct radioimmunoassay for antigens and their antibodies
NL171930C (en) 1972-05-11 1983-06-01 Akzo Nv METHOD FOR DETERMINING AND DETERMINING BITES AND TEST PACKAGING.
US3850578A (en) 1973-03-12 1974-11-26 H Mcconnell Process for assaying for biologically active molecules
US3935074A (en) 1973-12-17 1976-01-27 Syva Company Antibody steric hindrance immunoassay with two antibodies
US3996345A (en) 1974-08-12 1976-12-07 Syva Company Fluorescence quenching with immunological pairs in immunoassays
US4034074A (en) 1974-09-19 1977-07-05 The Board Of Trustees Of Leland Stanford Junior University Universal reagent 2-site immunoradiometric assay using labelled anti (IgG)
US3984533A (en) 1975-11-13 1976-10-05 General Electric Company Electrophoretic method of detecting antigen-antibody reaction
US4098876A (en) 1976-10-26 1978-07-04 Corning Glass Works Reverse sandwich immunoassay
US4879219A (en) 1980-09-19 1989-11-07 General Hospital Corporation Immunoassay utilizing monoclonal high affinity IgM antibodies
US5011771A (en) 1984-04-12 1991-04-30 The General Hospital Corporation Multiepitopic immunometric assay
US4666828A (en) 1984-08-15 1987-05-19 The General Hospital Corporation Test for Huntington's disease
US4683202A (en) 1985-03-28 1987-07-28 Cetus Corporation Process for amplifying nucleic acid sequences
US4801531A (en) 1985-04-17 1989-01-31 Biotechnology Research Partners, Ltd. Apo AI/CIII genomic polymorphisms predictive of atherosclerosis
US5272057A (en) 1988-10-14 1993-12-21 Georgetown University Method of detecting a predisposition to cancer by the use of restriction fragment length polymorphism of the gene for human poly (ADP-ribose) polymerase
US5192659A (en) 1989-08-25 1993-03-09 Genetype Ag Intron sequence analysis method for detection of adjacent and remote locus alleles as haplotypes
US5281521A (en) 1992-07-20 1994-01-25 The Trustees Of The University Of Pennsylvania Modified avidin-biotin technique
US6777196B2 (en) 1997-02-18 2004-08-17 Genentech, Inc. Neurturin receptor
AP9901686A0 (en) 1997-05-14 1999-12-31 Rhone Poulenc Rorer Pharma Peptide parathyroid hormone analogs.
CA3149553C (en) 2006-06-12 2023-11-21 Aptevo Research And Development Llc Single-chain multivalent binding proteins with effector function
AU2007278054B2 (en) 2006-07-24 2012-11-22 Yeda Research And Development Co. Ltd. Pharmaceutical compositions comprising CCL2 and use of same for the treatment of inflammation
FR2907341B1 (en) 2006-10-18 2012-08-17 Pf Medicament USE OF ANTI-CD151 ANTIBODY FOR THE TREATMENT OF CANCER
FR2929946B1 (en) 2008-04-11 2010-05-28 Pf Medicament NOVEL ANTI-CD151 ANTIBODIES AND THEIR USE FOR THE TREATMENT OF CANCER

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010137020A1 (en) * 2009-05-28 2010-12-02 Yeda Research And Development Co. Ltd. Methods of treating inflammation

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE Geneseq [Online] 24 January 2008 (2008-01-24), "Human tissue-derived glycoprotein peptide fragment SEQ ID NO:4850.", XP002683046, retrieved from EBI accession no. GSP:AJL89195 Database accession no. AJL89195 *
FLAISHON LIAT ET AL: "Anti-inflammatory effects of an inflammatory chemokine: CCL2 inhibits lymphocyte homing by modulation of CCL21-triggered integrin-mediated adhesions", BLOOD, AMERICAN SOCIETY OF HEMATOLOGY, US, vol. 112, no. 13, 1 December 2008 (2008-12-01), pages 5016 - 5025, XP009138924, ISSN: 0006-4971, DOI: 10.1182/BLOOD-2007-12-129122 *
YAUCH ROBERT L ET AL: "Highly stoichiometric, stable, and specific association of integrin alpha3beta1 with CD151 provides a major link to phosphatidylinositol 4-kinase, and may regulate cell migration", MOLECULAR BIOLOGY OF THE CELL, vol. 9, no. 10, October 1998 (1998-10-01), pages 2751 - 2765, XP002683047, ISSN: 1059-1524 *

Also Published As

Publication number Publication date
WO2012131680A9 (en) 2012-12-13
WO2012131680A2 (en) 2012-10-04

Similar Documents

Publication Publication Date Title
NZ602845A (en) Inhibiting peptides derived from trem-like transcript 1 (tlt-1) and uses thereof
WO2011121289A3 (en) Peptides and their use
WO2013000922A9 (en) Ccr2 antagonist peptides
EA201170878A1 (en) POLYPEPTIDES WITH XYLANASE ACTIVITY
WO2012160563A3 (en) Use of akt phosphorylation as a biomarker for prognosing neurodegenerative diseases and treating same
WO2013013085A3 (en) Anti-fibrotic peptides and their use in methods for treating diseases and disorders characterized by fibrosis
MX2010001856A (en) Protein.
WO2008093058A3 (en) Peptides and their use
WO2013164479A3 (en) Improved chymosine enzyme variants
WO2014202622A3 (en) Rasamsonia gene and use thereof
WO2014037565A3 (en) Inhibiting peptides derived from triggering receptor expressed on myeloid cells-1 (trem-1) trem-like transcript 1 (tlt-1) and uses thereof
WO2012012351A3 (en) High-protein beverages comprising whey protein
NZ609216A (en) Anticancer fusion protein
WO2015040609A8 (en) Erk-derived peptides and uses thereof
MX2015001542A (en) Method.
WO2010026219A3 (en) New tomato ethylene response factors and uses thereof
WO2016036635A8 (en) Chromobacterium subtsugae genes
WO2016092555A3 (en) Isolated phosphotriesterase polypeptides, polynucleotides encoding same and uses thereof in treating or preventing organophosphate exposure associated damage
WO2010103515A3 (en) Compositions and methods for prevention and treatment of neurodegenerative diseases
WO2012031103A3 (en) Inhibitors of bcl-2
WO2011135222A3 (en) Use of peptides as transporters intended for the internalization of molecules of interest into target cells
WO2012131680A3 (en) Compositions and methods for treating inflammation based on inhibiting cd151 activity
WO2013088371A3 (en) Use of the mmp-12 protein in the prevention and/or treatment of dandruff conditions of the scalp
MX2010010177A (en) Improved beta thymosin fragments.
CA2909744C (en) Protransduzin b, an enhancer of gene transfer

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 12720011

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 12720011

Country of ref document: EP

Kind code of ref document: A2